ASX:XRF
XRF Scientific Limited
Investment Summary
The fund managers believe that XRF Scientific Limited (XRF) is exhibiting solid performance, noting revenue stability coupled with a 12% increase in profit. In their opinion, this steady execution reflects positively on the company’s management and operational efficiency. Despite the current share price of approximately $1.97, they observe that the market initially reacted favorably to these results. However, they caution about the typical market behavior of sharp profit-taking following initial gains, suggesting that investors should be aware of potential volatility in the short term. Overall, the fund managers maintain a cautiously optimistic outlook as they monitor market conditions.
Commentary From The Managers
Mereweather Capital
28 Feb 2025
$1.97
- Mereweather Capital notes that XRF Scientific (XRF) has maintained steady execution.
- Despite revenue remaining flat, profit has increased by 12%.
- The market reacted positively to the results initially, highlighting a strong reward for the outcome.
- However, there has been subsequent profit taking as market conditions shifted.
- Mereweather Capital continues to hold shares due to the company's resilience and potential for growth.
Please note: The completeness, accuracy or current status of the investments referenced are not guaranteed.